Names of participants - see below the article

The role of extended treatment discussed by mastitis experts

‘The benefit of extended therapy for mastitis, myth or fact?’ was the topic at the third global milk quality expert forum,… This content is for M²-DIGITAL, M²-PREMIUM, M²-PARTNERS & NMC members only.Login or  Join Now and get instant Premium access....

This content is for M²-DIGITAL, M²-PREMIUM, M²-PARTNERS & NMC members only.
Login or  Join Now and get instant Premium access.

Read more

Ubrocare.com: Experts in mastitis

As part of the Ubrocare program for the mastitis prevention and treatment, Boehringer Ingelheim has recently launched Ubrocare.com. This is an innovative multidevice website through which you will be able to become an expert in mastitis!… This content is for...

This content is for M²-DIGITAL, M²-PREMIUM, M²-PARTNERS & NMC members only.
Login or  Join Now and get instant Premium access.

Read more
The Global Milk Quality Expert Forum is a group of independent experts from acadaemia and practice facilitated by Boehringer Ingelheim’s global udder health team.

Global Milk Quality Expert Forum meeting in Copenhagen sees lively discussion

Boehringer Ingelheim’s second Quality Milk Expert Forum entitled ‘What is the future of dry cow therapy?’… This content is for M²-DIGITAL, M²-PREMIUM, M²-PARTNERS & NMC members only.Login or  Join Now and get instant Premium access....

This content is for M²-DIGITAL, M²-PREMIUM, M²-PARTNERS & NMC members only.
Login or  Join Now and get instant Premium access.

Read more
In total, 4580 Staphylococcus aureus, 6125 Streptococcus uberis, 2264 Streptococcus dysgalactiae, 3287 Escherichia coli and 1066 coagulase-negative staphylococci were analyzed, showing 96.7%, 94.7%, 99.2%, 88.5% and 98.1% susceptible strains, respectively. (Photo S. Piepers)

Boehringer Ingelheim at the National Mastitis Council Regional Meeting in Ghent

Boehringer Ingelheim is very proud to be one of the major sponsors of the first National Mastitis Council (NMC) meeting to be held in Europe, where it will present two posters on Ubrolexin®.

Read more